[[{“type”:“media”,“view_mode”:“media_large”,“fid”:null,“attributes”:{“class”:“media-image alignright size-full wp-image-1604”,“typeof”:“foaf:Image”,“style”:“”,“width”:“100”,“height”:“100”,“alt”:“Los Angeles Times”}}]]Citing a new study and accompanying commentary by Harold C. Sox, active emeritus of medicine at The Geisel School of Medicine and associate director for faculty at The Dartmouth Institute for Health Policy and Clinical Practice, the Los Angeles Times writes about a new approach to the continuing debate over prostate cancer screening.

Using a system of numbers to reflect “quality of life,” the new study determined that testing has benefits, but found that the overall benefits are decreased when the “quality of life” factor—men’s feelings about the test’s outcomes—is taken into account, the Los Angeles Times reports.

Sox writes in his commentary that taking into account how men feel about outcomes is important when weighing a recommendation for or against the screening.

Read the full story, published 8/16/12 in the Los Angeles Times. Sox is also quoted in stories that ran in Reuters, WebMD, and MedPage Today.